S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
Positive News SentimentPositive News

Harmony Biosciences (HRMY) Earnings Date, Estimates & Call Transcripts

$31.00
-0.05 (-0.16%)
(As of 12/8/2023 ET)
Compare
Today's Range
$30.96
▼
$31.86
50-Day Range
$19.20
▼
$32.60
52-Week Range
$18.61
▼
$61.42
Volume
491,755 shs
Average Volume
703,880 shs
Market Capitalization
$1.82 billion
P/E Ratio
12.60
Dividend Yield
N/A
Price Target
$50.43
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Feb. 20Estimated
Actual EPS
(Oct. 31)
$0.63 Missed By -$0.04
Consensus EPS
(Oct. 31)
$0.67
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

HRMY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

HRMY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Harmony Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20233$0.42$0.57$0.47
Q2 20233$0.53$0.69$0.62
Q3 20233$0.53$0.74$0.65
Q4 20233$0.61$0.78$0.72
FY 202312$2.09$2.78$2.45

HRMY Earnings Date and Information

Harmony Biosciences last announced its quarterly earnings results on October 31st, 2023. The reported $0.63 earnings per share for the quarter, missing the consensus estimate of $0.67 by $0.04. The firm had revenue of $160.30 million for the quarter, compared to analyst estimates of $147.83 million. Its quarterly revenue was up 36.8% on a year-over-year basis. Harmony Biosciences has generated $2.46 earnings per share over the last year ($2.46 diluted earnings per share) and currently has a price-to-earnings ratio of 12.6. Earnings for Harmony Biosciences are expected to grow by 37.50% in the coming year, from $2.56 to $3.52 per share. Harmony Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 20th, 2024 based off prior year's report dates.

Harmony Biosciences Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/20/2024
Estimated)		------- 
10/31/2023Q3 2023$0.67$0.63($0.04)$0.63$147.83 million$160.30 million    
8/1/2023Q2 2023$0.62$0.56($0.06)$0.56$139.79 million$134.22 million
5/2/2023Q1 2023$0.44$0.48+$0.04$0.48$118.21 million$119.13 million
2/21/2023Q4 2022$0.54$1.01+$0.47$1.23$127.73 million$128.31 million
11/1/2022Q3 2022$0.10$0.95+$0.85$0.46$113.11 million$117.21 million
8/2/2022Q2 2022$0.40$0.57+$0.17$0.75$99.35 million$107.03 million    
5/3/2022Q1 2022$0.25$0.51+$0.26$0.67$87.77 million$85.31 million    
2/28/2022Q4 2021$0.32$0.63+$0.31$0.88$88.43 million$91.21 million    
11/8/2021Q3 2021$0.29($0.17)($0.46)$1.03$79.30 million$80.73 million  
8/9/2021Q2 2021$0.18$0.24+$0.06$0.84$70.85 million$73.82 million    
5/10/2021Q1 2021($0.03)$0.38+$0.41$0.63$59.60 million$59.67 million  
3/24/2021Q4 2020$0.09$0.25+$0.16$0.50$51.50 million$56.29 million  












Harmony Biosciences Earnings - Frequently Asked Questions

When is Harmony Biosciences's earnings date?

Harmony Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 20th, 2024 based off last year's report dates. Learn more on HRMY's earnings history.

Did Harmony Biosciences beat their earnings estimates last quarter?

In the previous quarter, Harmony Biosciences (NASDAQ:HRMY) missed the analysts' consensus estimate of $0.67 by $0.04 with a reported earnings per share (EPS) of $0.63. Learn more on analysts' earnings estimate vs. HRMY's actual earnings.

How can I listen to Harmony Biosciences's earnings conference call?

The conference call for Harmony Biosciences's latest earnings report can be listened to online. Listen to Conference Call

How can I read Harmony Biosciences's conference call transcript?

The conference call transcript for Harmony Biosciences's latest earnings report can be read online. Read Transcript

How much revenue does Harmony Biosciences generate each year?

Harmony Biosciences (NASDAQ:HRMY) has a recorded annual revenue of $541.92 million.

How much profit does Harmony Biosciences generate each year?

Harmony Biosciences (NASDAQ:HRMY) has a recorded net income of $181.47 million. HRMY has generated $2.46 earnings per share over the last four quarters.

What is Harmony Biosciences's price-to-earnings ratio?

Harmony Biosciences (NASDAQ:HRMY) has a trailing price-to-earnings ratio of 12.60 and a forward price-to-earnings ratio of 12.11. The price/earnings-to-growth ratio is 0.87.

What is Harmony Biosciences's EPS forecast for next year?

Harmony Biosciences's earnings are expected to grow from $2.56 per share to $3.52 per share in the next year, which is a 37.50% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:HRMY) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -